# A Patient-Directed Mobile Tool to Streamline the QoL Assessment and Monitoring in Urothelial Carcinoma

> **NCT06982794** · — · RECRUITING · sponsor: **IRCCS San Raffaele** · enrollment: 50 (estimated)

## Conditions studied

- Urothelial Carcinoma (UC)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06982794
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-30
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-10-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06982794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06982794, "A Patient-Directed Mobile Tool to Streamline the QoL Assessment and Monitoring in Urothelial Carcinoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06982794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*